Bay Street News, 2025

SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to […]

CLEARWATER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) — Apyx® Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”), the manufacturer of a […]

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company […]

Canada and United Kingdom represent two of the largest markets within the ALK portfolio with plans to expand filings of […]

WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to […]

BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted […]

BEDMINSTER, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) — Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today announced that members […]

ATLANTA, Jan. 06, 2025 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of […]

OTTAWA, Ontario and ARLINGTON, Va., Jan. 06, 2025 (GLOBE NEWSWIRE) — Telesat (NASDAQ and TSX: TSAT), one of the world’s […]

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Sparton Resources (TSX-SRI-V), (“the Company”), is pleased to announce that news of positive […]